RPRXROYALTY PHARMA PLC- CL A
CUSIP G7709Q104 · common stock
5 tracked investors held ROYALTY PHARMA PLC- CL A (RPRX) at the end of Q3 2026, worth $395M in total. The largest holder was Samantha McLemore, with 6.3% of its portfolio.
Holders · Q3 2026
5
New holders
0
Value held
$395M
Quarter-end price (est.)
$58.36
Investors holding RPRX · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Samantha McLemore Patient Capital Management, LLC | 6.35% | 3,422,067 | $199.7M | REDUCE-4.9% |
| Pat Dorsey Dorsey Asset Management, LLC | 8.23% | 2,415,667 | $141M | REDUCE-1.7% |
| Torray Funds Torray Investment Partners LLC | 4.35% | 564,461 | $32.9M | REDUCE-6.2% |
| Murray Stahl Horizon Kinetics Asset Management LLC | 0.26% | 353,191 | $20.6M | ADD+2.4% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.03% | 12,500 | $729.5K | HOLD |